Medical Device Network on MSN1 天
Vivani Medical to spin-off neurostim business Cortigent as public company
Vivani was created in 2022 when subdermal drug implant company Nano Precision Medical merged with implantable visual ...
EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better ...
Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant ...
Medical Dialogues2 天
FDA Approves Encelto for treatment of Macular Telangiectasia Type 2
The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...
Optometry Advisor4 天
FDA Approves Encelto for Macular Telangiectasia Type 2
The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).
Fierce Pharma4 天
Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
The Daily Galaxy on MSN4 天
Sounds Like Science Fiction: Doctors Implant a Tooth in a Man’s Eye—Now He Can See Again
When Brent Chapman first heard his doctor suggest surgically implanting one of his own teeth into his eye to restore his ...
MedPage Today6 天
FDA Approves Ocular Implant for Vision-Threatening MacTel
The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ...